Metastatic Lung Neuroendocrine Neoplasm
Oncology
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Metastatic Lung Neuroendocrine Neoplasm?
There are 1 clinical trial targeting Metastatic Lung Neuroendocrine Neoplasm tracked by BioSniper.
What is the prevalence of Metastatic Lung Neuroendocrine Neoplasm?
The estimated prevalence of Metastatic Lung Neuroendocrine Neoplasm is approximately 30.0 per 100,000 population.
Deep-dive into Metastatic Lung Neuroendocrine Neoplasm
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis